{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:43:10Z","timestamp":1778575390303,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>The College of American Pathologists recognizes \u201cintraductal papillary neoplasm of the bile ducts (IPNB) with an associated invasive carcinoma\u201d in its protocols for the pancreas and intrahepatic bile ducts, but not for the perihilar or distal bile ducts. We aimed to investigate the clinicopathologic and molecular features of 27 surgically resected perihilar IPNB cases. The cohort included 14 males and 13 females, with a median age of 70 years. Six IPNBs were noninvasive, while 21 had associated invasive carcinoma. The median overall tumor size was 2.8\u00a0cm, and the median invasive tumor size was 1.2\u00a0cm. Eight of 16 patients had elevated CA19-9. Immunohistochemistry as a surrogate of molecular analysis was performed in 19 cases with invasive carcinoma. Among them, positive PD-L1 expression was found in 3 cases (15.8%, all had low expression, CPS&lt;5). DNA mismatch repair deficiency (loss of MSH2 and MSH6) and p53 overexpression were each identified in 1 case (5.3%). All cases were negative for HER2 and pan-TRK. After a median follow-up of 38 months, 11 patients died of disease. Next-generation sequencing revealed genetic alterations impacting multiple signaling pathways, including MAPK\/ERK, WNT\/\u03b2-catenin, TGF-\u03b2, DNA damage response, and PI3K\/AKT. Our case series suggests that IPNB with associated invasive carcinoma may be included in CAP protocols as one of the carcinoma types of perihilar bile ducts. Future studies are warranted to compare perihilar IPNB with those originating in other biliary tract sites. We expect our molecular findings to help guide the selection of potential therapeutic targets.<\/jats:p>","DOI":"10.1097\/pas.0000000000002507","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:00:11Z","timestamp":1768885211000},"page":"376-387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Perihilar Intraductal Papillary Neoplasm of the Bile Ducts"],"prefix":"10.1097","volume":"50","author":[{"given":"Ahmad","family":"Alkashash","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Samiei","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaomin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Wake Forest University, Winston-Salem, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-7204","authenticated-orcid":false,"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN"},{"name":"Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"R2-20260218","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ajg.2011.316","article-title":"Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype","volume":"107","author":"Kim","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R3-20260218","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semdp.2016.12.013","article-title":"Biliary tumors with pancreatic counterparts","volume":"34","author":"Nakanuma","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"R4-20260218","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.21387","article-title":"Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Zen","year":"2006","journal-title":"Hepatology"},{"key":"R5-20260218","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/modpathol.2013.112","article-title":"Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways","volume":"27","author":"Schlitter","year":"2014","journal-title":"Mod Pathol"},{"key":"R6-20260218","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2012.05.008","article-title":"Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct","volume":"57","author":"Jung","year":"2012","journal-title":"J Hepatol"},{"key":"R7-20260218","first-page":"207","article-title":"Morphological classification of intraductal papillary neoplasm of the bile duct with survival correlation","volume":"18","author":"Luvira","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R8-20260218","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2015.12.022","article-title":"Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm","volume":"51","author":"Nakanuma","year":"2016","journal-title":"Hum Pathol"},{"key":"R9-20260218","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jhbp.23","article-title":"Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association","volume":"21","author":"Kubota","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R10-20260218","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.25786","article-title":"Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?","volume":"56","author":"Rocha","year":"2012","journal-title":"Hepatology"},{"key":"R11-20260218","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.3748\/wjg.v19.i46.8595","article-title":"Intraductal papillary neoplasm of the bile duct","volume":"19","author":"Wan","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R12-20260218","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2214\/AJR.17.19261","article-title":"Intraductal papillary neoplasm of the bile duct: clinical, imaging, and pathologic features","volume":"211","author":"Park","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"R13-20260218","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3346\/jkms.2010.25.7.1011","article-title":"Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea","volume":"25","author":"Shin","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R14-20260218","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhbp.785","article-title":"Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study","volume":"27","author":"Kubota","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R15-20260218","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.25590","article-title":"Cystic and papillary neoplasm involving peribiliary glands: a biliary counterpart of branch-type intraductal papillary mucinous [corrected] neoplasm?","volume":"55","author":"Nakanuma","year":"2012","journal-title":"Hepatology"},{"key":"R16-20260218","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/his.13125","article-title":"RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct","volume":"70","author":"Tsai","year":"2017","journal-title":"Histopathology"},{"key":"R17-20260218","doi-asserted-by":"crossref","first-page":"e81706","DOI":"10.1371\/journal.pone.0081706","article-title":"GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct","volume":"8","author":"Sasaki","year":"2013","journal-title":"PLoS One"},{"key":"R18-20260218","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/PAS.0b013e3182986bb5","article-title":"GNAS is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct","volume":"37","author":"Tsai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R19-20260218","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PAS.0b013e3182103f36","article-title":"Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion","volume":"35","author":"Ohtsuka","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R20-20260218","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.3390\/jcm9123991","article-title":"Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations","volume":"9","author":"Nakanuma","year":"2020","journal-title":"J Clin Med"},{"key":"R21-20260218","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00428-017-2144-9","article-title":"Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes","volume":"471","author":"Fukumura","year":"2017","journal-title":"Virchows Arch"},{"key":"R22-20260218","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.humpath.2010.09.017","article-title":"A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas","volume":"42","author":"Kloek","year":"2011","journal-title":"Hum Pathol"},{"key":"R23-20260218","doi-asserted-by":"crossref","first-page":"422","DOI":"10.21037\/hbsn-22-1","article-title":"Editorial on \u201cPerihilar Cholangiocarcinoma-Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers\u201d","volume":"11","author":"Sivakumar","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R24-20260218","doi-asserted-by":"crossref","first-page":"164","DOI":"10.15430\/JCP.2020.25.3.164","article-title":"Gallstones, cholecystectomy and the risk of hepatobiliary and pancreatic cancer: a nationwide population-based cohort study in Korea","volume":"25","author":"Huang","year":"2020","journal-title":"J Cancer Prev"},{"key":"R25-20260218","doi-asserted-by":"crossref","first-page":"59648","DOI":"10.18632\/oncotarget.19570","article-title":"Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma","volume":"8","author":"Xiong","year":"2017","journal-title":"Oncotarget"},{"key":"R26-20260218","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hep.20837","article-title":"Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions","volume":"42","author":"Yeh","year":"2005","journal-title":"Hepatology"},{"key":"R27-20260218","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41379-019-0306-9","article-title":"Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct","volume":"32","author":"Yang","year":"2019","journal-title":"Mod Pathol"},{"key":"R28-20260218","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/path.5398","article-title":"Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes","volume":"251","author":"Aoki","year":"2020","journal-title":"J Pathol"},{"key":"R29-20260218","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"R30-20260218","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"R31-20260218","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/jcm8040435","article-title":"PARP inhibitors as a therapeutic agent for homologous recombination deficiency in breast cancers","volume":"8","author":"Keung","year":"2019","journal-title":"J Clin Med"},{"key":"R32-20260218","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","article-title":"Targeting DNA damage response in cancer therapy","volume":"105","author":"Hosoya","year":"2014","journal-title":"Cancer Sci"},{"key":"R33-20260218","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"R34-20260218","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbacli.2015.11.003","article-title":"The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials","volume":"5","author":"Malley","year":"2016","journal-title":"BBA Clin"},{"key":"R35-20260218","doi-asserted-by":"crossref","first-page":"e404770","DOI":"10.1200\/EDBK_404770","article-title":"Expanding the benefit: dabrafenib\/trametinib as tissue-agnostic therapy for BRAF V600E-positive adult and pediatric solid tumors","volume":"43","author":"Gouda","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R36-20260218","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1038\/s41598-018-25669-1","article-title":"Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma","volume":"8","author":"Simbolo","year":"2018","journal-title":"Sci Rep"},{"key":"R37-20260218","doi-asserted-by":"crossref","first-page":"20220652","DOI":"10.1515\/biol-2022-0652","article-title":"Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis","volume":"18","author":"Peng","year":"2023","journal-title":"Open Life Sci"},{"key":"R38-20260218","doi-asserted-by":"crossref","first-page":"1534005","DOI":"10.3389\/fonc.2025.1534005","article-title":"Clinical significance of HER2 overexpression in biliary tract carcinoma\u2013a meta-analysis","volume":"15","author":"Xu","year":"2025","journal-title":"Front Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:00:18Z","timestamp":1771394418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002507"}},"subtitle":["A Clinicopathologic and Molecular Genetic Study of 27 Cases"],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002507","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}